Gainesville, FL7 Active Studies

Spinal Muscular Atrophy Clinical Trials in Gainesville, FL

Find 7 actively recruiting spinal muscular atrophy clinical trials in Gainesville, FL. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
1,759
Enrolling

Recruiting Spinal Muscular Atrophy Studies in Gainesville

NCT07513376Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Researchers are looking for new ways to treat high-risk, localized non-small cell lung cancer (NSCLC) that has been removed with surgery. People with high-risk, localized NSCLC are often treated with...

Gainesville, FLPHASE3876 participantsMerck Sharp & Dohme LLC
View Study Details
NCT07100080Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy...

Gainesville, FLPHASE2500 participantsBristol-Myers Squibb
View Study Details
NCT07155174Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, a...

Gainesville, FLPHASE2180 participantsAbbVie
View Study Details
NCT07393555Recruiting

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

This phase II Expanded Lung-MAP treatment trial compares how well sacituzumab govitecan alone, ivonescimab alone, or sacituzumab govitecan in combination with ivonescimab works in treating patients wi...

Gainesville, FLPHASE2117 participantsSWOG Cancer Research Network
View Study Details
NCT06863480Recruiting

Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

In this study, tocilizumab-aazg (TYENNE) will be administered to see whether tocilizumab-aazg is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst bra...

Gainesville, FLPHASE130 participantsUniversity of Florida
View Study Details
NCT05861986Recruiting

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

This is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered as an early intervention in pediatric participants with spinal muscular...

Gainesville, FLPHASE428 participantsHoffmann-La Roche
View Study Details
NCT05861999Recruiting

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

This is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered in pediatric participants with SMA and 2 SMN2 copies who previously rec...

Gainesville, FLPHASE428 participantsHoffmann-La Roche
View Study Details

About Spinal Muscular Atrophy Clinical Trials in Gainesville

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.

There are currently 7 spinal muscular atrophy clinical trials recruiting participants in Gainesville, FL. These studies are seeking a combined 1,759 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Bristol-Myers Squibb, AbbVie and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Muscular Atrophy Clinical Trials in Gainesville — FAQ

Are there spinal muscular atrophy clinical trials in Gainesville?

Yes, there are 7 spinal muscular atrophy clinical trials currently recruiting in Gainesville, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gainesville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gainesville research site will contact you about next steps.

Are clinical trials in Gainesville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gainesville studies also compensate for your time and travel.

What spinal muscular atrophy treatments are being tested?

The 7 active trials in Gainesville are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.

Data updated October 15, 2026 from ClinicalTrials.gov